Far-UVC light dramatically reduced airborne virus levels in a room where people were working, in the first study of the new air disinfection technology outside of an experimental setting.
Hachung Chung’s curiosity about the immune system is now leading her to delve into a longstanding question: Why is the brain so prone to inflammation in the absence of pathogens?
The COVID pandemic transformed students’ education but also imparted profound experiences that students say will make them stronger practitioners and leaders.
Columbia health care workers tell us about the pandemic’s toll on their lives and what CUIMC is doing to alleviate the burden. Emotional support, self-care, and instilling hope are key.
New insights by Columbia researchers into MIS-C, a rare but serious complication of COVID in children, may lead to faster diagnosis and better treatment.
COVID vaccines and monoclonal antibody treatments offer less protection against new omicron subvariants, a new study from researchers at Columbia and University of Hong Kong finds.
Columbia researchers could receive up to $9.4 million to learn about long COVID in children and young adults as part of NIH’s REsearching COVID to Enhance Recovery (RECOVER) initiative.
A common virus that causes no harm in most people may be a danger to organ transplant recipients and other immunocompromised people, Columbia University researchers have found.
A study reports that the brains of a small sample of patients who died of COVID display some of the same molecular changes found in the brains of people with Alzheimer's disease.
Computer modeling of the omicron wave by Mailman's Jeffrey Shaman suggests case numbers may subside as quickly as they climbed, peaking by mid-January in New York City.